Elisabeth Huis/LinkedIn
Sep 21, 2025, 16:27
Elisabeth Huis Guides Winning Team at ECDHM 2025 Hackathon on Predictive Stock and Donor Engagement
Elisabeth Huis, Assistant Professor at the Department of Cognitive Science and Artificial Intelligence at Tilburg University, posted on LinkedIn:
”The winning group of the ECDHM 2025 hackathon (with óne vote extra) demonstrated how:
- You can use data from stock levels to accurately visualise current stock,
- and how you could potentially use it to predict future stock,
- which can be accurately visualised with a dynamic Graphic User Interface, (GUI), to instill a sense of urgency in donors in a visually engaging way,
- how these can be further harnassed by implementing A/B testing and ‘nudges’,
- which combined with an ‘appointment’ function can be used to immediately encourage donors to make appointment,
- and which can assess which behavioral strategies work best for donor recruitment and retention.
Mentor/challenger: Richard Mills, NHS Blood and Transplant
Group: Jess Severijns, Joris van Eijkelenburg, Stefan Hasenoot, Gaia Naumann, Frey Mink, CSAI students from Tilburg University, Tilburg School of Humanities and Digital Sciences
Thanks for MindLabs for hosting us.”
Stay updated with Hemostasis Today.
Blood donation
Blood Stocks
ECDHM 2025
Elisabeth Huis
Frey Mink
Gaia Naumann
Health
Hematology
Hemostasis
Hemostasis Today
ilburg School of Humanities and Digital Sciences
Jess Severijns
Joris van Eijkelenburg
Medicine
MindLabs
NHS Blood and Transplant
Richard Mills
Stefan Hasenoot
thrombosis
Tilburg Universit
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals
Sep 29, 2025, 12:54
Sep 29, 2025, 12:33
Sep 29, 2025, 06:23
Sep 29, 2025, 05:06
Sep 29, 2025, 04:28